1. Home
  2. OPHC vs BDSX Comparison

OPHC vs BDSX Comparison

Compare OPHC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimumBank Holdings Inc.

OPHC

OptimumBank Holdings Inc.

N/A

Current Price

$4.34

Market Cap

47.3M

Sector

Finance

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$7.56

Market Cap

62.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPHC
BDSX
Founded
2000
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.3M
62.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OPHC
BDSX
Price
$4.34
$7.56
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
38.9K
63.1K
Earning Date
02-04-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
89.25
N/A
EPS
1.30
N/A
Revenue
$43,818,000.00
$80,173,000.00
Revenue This Year
N/A
$20.75
Revenue Next Year
N/A
$25.05
P/E Ratio
$3.34
N/A
Revenue Growth
26.98
22.29
52 Week Low
$3.53
$3.44
52 Week High
$5.04
$32.20

Technical Indicators

Market Signals
Indicator
OPHC
BDSX
Relative Strength Index (RSI) 60.21 50.10
Support Level $4.11 $7.77
Resistance Level $4.34 $8.38
Average True Range (ATR) 0.07 0.55
MACD 0.02 -0.04
Stochastic Oscillator 76.49 30.61

Price Performance

Historical Comparison
OPHC
BDSX

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: